General MedicationsINJECTIONStandard
OCTREOTIDE ACETATE
OCTREOTIDE ACETATE
Standard Dose
EQ 1MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview OCTREOTIDE ACETATE is listed in Drugs@FDA under application 216807 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient OCTREOTIDE ACETATE Form and strength INJECTABLE;INJECTION - EQ 1MG BASE/ML Sponsor GLAND Submission history Latest submission status date: 2024-09-30 00:00:00.
Structured Monograph
Clinical summary
Approval overview OCTREOTIDE ACETATE is listed in Drugs@FDA under application 216807 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient OCTREOTIDE ACETATE Form and strength INJECTABLE;INJECTION - EQ 1MG BASE/ML Sponsor GLAND Submission history Latest submission status date: 2024-09-30 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.